SuperworthAnaptysbio shares outstanding ANAB
Diluted shares outstanding, averaged over each quarter, from 2016.
- Latest quarter, to Jun 30, 2026
- 37.8M
- On a year earlier
- −9.4%
- fewer shares
Anaptysbio had 37.8M diluted shares outstanding on average in Q4 FY26, the quarter to Jun 30, 2026.
That is 9.4% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 37.8M | −9% |
| FY2025 | 41.7M | −9% |
| FY2024 | 45.7M | +15% |
| FY2023 | 39.9M | −7% |
| FY2022 | 42.7M | +3% |
| FY2021 | 41.3M | +1% |
| FY2020 | 41M | +1% |
| FY2019 | 40.8M | +1% |
| FY2018 | 40.2M | +16% |
| FY2017 | 34.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY26 | 37.8M | −9% | |
| Q2 FY26 | 28.7M | −34% | |
| Q4 FY25 | 41.7M | −9% | |
| Q3 FY25 | 43.5M | +0% | |
| Q2 FY25 | 43.2M | +5% | |
| Q1 FY25 | 46M | +14% | |
| Q4 FY24 | 45.7M | +15% | |
| Q3 FY24 | 43.3M | +9% | |
| Q2 FY24 | 41M | +3% | |
| Q1 FY24 | 40.2M | −4% | |
| Q4 FY23 | 39.9M | −7% | |
| Q3 FY23 | 39.8M | −6% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Anaptysbio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.